Tipiracil
Lonsurf (tipiracil) is a small molecule pharmaceutical. Tipiracil was first approved as Lonsurf on 2015-09-22. It is used to treat colorectal neoplasms in the USA. It has been approved in Europe to treat colorectal neoplasms. Lonsurf's patents are valid until 2037-02-03 (FDA).
| Trade Name | Lonsurf |
|---|---|
| Common Name | Tipiracil |
| Indication | colorectal neoplasms |
| Drug Class | Uracil type antineoplastics |
